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Alterations in AMPA receptor subunits and TARPs in the rat
nucleus accumbens related to the formation of Ca2+-permeable
AMPA receptors during the incubation of cocaine craving
Carrie R. Ferrarioa,1, Jessica A. Lowetha, Mike Milovanovica, Kerstin A. Forda, Gregorio L.
Galiñanesb,2, Li-Jun Hengb, Kuei Y. Tsengb, and Marina E. Wolfa
aDepartment of Neuroscience, Rosalind Franklin University of Medicine and Science, 3333 Green
Bay Road, North Chicago, Il 60064-3095
bDepartment of Cellular and Molecular Pharmacology, Rosalind Franklin University of Medicine
and Science, 3333 Green Bay Road, North Chicago, Il 60064-3095
Abstract
Cue-induced cocaine seeking intensifies or incubates after withdrawal from extended access
cocaine self-administration, a phenomenon termed incubation of cocaine craving. The expression
of incubated craving is mediated by Ca2+-permeable AMPA receptors (CP-AMPARs) in the
nucleus accumbens (NAc). Thus, CP-AMPARs are a potential target for therapeutic intervention,
making it important to understand mechanisms that govern their accumulation. Here we used
subcellular fractionation and biotinylation of NAc tissue to examine the abundance and
distribution of AMPAR subunits, and GluA1 phosphorylation, in the incubation model. We also
studied two transmembrane AMPA receptor regulatory proteins (TARPs), γ2 and γ4. Our results,
together with earlier findings, suggest that some of the new CP-AMPARs are synaptic. These are
probably associated with γ2, but they are loosely tethered to the PSD. Levels of GluA1
phosphorylated at serine 845 (pS845 GluA1) were significantly increased in biotinylated tissue
and in an extrasynaptic membrane-enriched fraction. These results suggest that increased synaptic
levels of CP-AMPARs may result in part from an increase in pS845 GluA1 in extrasynaptic
membranes, given that S845 phosphorylation primes GluA1-containing AMPARs for synaptic
insertion and extrasynaptic AMPARs supply the synapse. Some of the new extrasynaptic CP-
AMPARs are likely associated with γ4, rather than γ2. The maintenance of CP-AMPARs in NAc
synapses during withdrawal is accompanied by activation of CaMKII and ERK2 but not CaMKI.
Overall, AMPAR plasticity in the incubation model shares some features with better described
forms of synaptic plasticity, although the timing of the phenomenon and the persistence of related
neuroadaptations is significantly different.
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Relapse to cocaine use, even after a long period of abstinence, is a critical problem in
treating addiction. Relapse is often triggered by craving elicited by cues or contexts
previously associated with cocaine (O’Brien et al., 1992). A number of different models
exist for studying cue-induced cocaine craving in rats (e.g., Crombag et al., 2008). We are
particularly interested in the incubation model. Incubation refers to the progressive
intensification of cue-induced cocaine-seeking that occurs after withdrawal from extended
access cocaine self-administration. Enhanced drug-seeking in this rat model persists >3
months after the last cocaine exposure (Lu et al., 2004). The incubation model is particularly
relevant to human cocaine users who undergo prolonged abstinence due to incarceration or
hospitalization, and then, once released, encounter previously drug-paired cues that can
trigger relapse (Reichel and Bevins, 2009).
Our studies focus on the role of AMPA-type glutamate receptors (AMPARs) in the
incubation of cocaine craving. AMPARs are tetramers composed of GluA1-4 subunits
(Shepherd and Huganir, 2007). They are associated with auxiliary subunits, including a
family of transmembrane AMPA receptor regulatory proteins (TARPs) that regulate
AMPAR trafficking, channel properties, and glutamate affinity (Kato et al., 2010). Medium
spiny neurons, the output neurons of the nucleus accumbens (NAc), are excited primarily by
AMPARs. This is required for drug seeking in many rat models of cocaine addiction,
suggesting AMPAR transmission in the NAc as a key control point for craving and relapse
(Kalivas, 2009; Wolf and Ferrario, 2010). Therefore, it is important to compare AMPAR
transmission in the NAc of drug-naïve rats and rats that have undergone incubation
(“incubated rats”).
While most AMPARs in the brain contain the GluA2 subunit, there has been considerable
recent interest in AMPARs that lack this subunit; these receptors are Ca2+-permeable (CP-
AMPARs) and have higher conductance than GluA2-containing, Ca2+-impermeable
AMPARs (CI-AMPARs; Cull-Candy et al., 2006; Isaac et al., 2007; Liu and Zukin, 2007).
Our recent studies have shown that CP-AMPARs are expressed at very low levels in NAc
synapses of adult drug-naïve rats (Conrad et al., 2008; Reimers et al., 2010), but accumulate
in association with the incubation of cue-induced cocaine craving and mediate its expression
in rats tested on withdrawal day (WD) 45 (Conrad et al., 2008). The presence of CP-
AMPARs in NAc synapses of “incubated rats” was demonstrated using electrophysiological
techniques, a bis(sulfosuccinimidyl)suberate (BS3) protein crosslinking assay showing
increased cell surface levels of GluA1 but not GluA2, and co-immunoprecipitation
experiments showing an increase in levels of GluA1 not physically associated with other
AMPAR subunits (Conrad et al., 2008). Although we first demonstrated CP-AMPARs in the
NAc core of “incubated rats”, we recently showed that they are also present in the rat NAc
shell on WD35-49 (McCutcheon et al., 2010). CP-AMPARs have also been detected in the
mouse NAc shell after 35 days of withdrawal from extended access cocaine self-
administration (Mameli et al., 2009).
The goal of the present study was to learn more about the subcellular distribution of CP-
AMPARs in the NAc of “incubated rats” and to understand how these receptors gain access
to NAc synapses and accumulate there during withdrawal. To this end, we used subcellular
fractionation and biotinylation to examine the abundance and subcellular distribution of
AMPAR subunits, as well as GluA1 phosphorylated at serine 845 (pS845 GluA1), in NAc
tissue obtained from control rats or “incubated rats” on WD30-45. We also studied two
TARPs, γ2 and γ4, that we have previously shown are expressed in the adult rat NAc
(Ferrario et al., in press). No prior studies have evaluated the effect of cocaine (or other
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drugs of abuse) on TARP expression or distribution. Finally, we measured the activation of
several signaling pathways previously linked to AMPAR plasticity.
2. Methods
2.1 Subjects and surgical procedures
All procedures were approved by the Rosalind Franklin University of Medicine and Science
Animal Care and Use Committee. Ninety-five Male Sprague Dawley rats (Harlan; 250–
275g) were individually housed (12:12 dark/light). All self-administration sessions were
conducted in the dark phase of the cycle with food and water available continually. For
catheter implantation, rats were anesthetized with isoflurane gas (Henry Schein, Melville,
NY) and given the analgesic banamine (2 mg/kg s.c.) prior to surgery. A silastic catheter
(Plastics one, Roanoke, VA) was inserted into the right jugular vein, passed under the skin
over the right shoulder and fixed in the mid-scapular region. Rats were given 7 days to
recover from surgery prior to beginning self-administration. During this time, catheters were
flushed every 1–2 days with sterile saline (0.1 ml, 0.9%).
2.2 Cocaine self-administration
Seven days after surgery, rats began self-administration sessions. Sessions (6 h) were
conducted once per day for 10 consecutive days, as in our previous study (Conrad et al.,
2008). Self-administration chambers (MED Associates, St. Albans, VT) were located within
sound and light attenuating cabinets and were equipped with 2 nose-poke ports located on
opposite sides of the chamber, 2 cm above the floor. Responding in one port (active)
resulted in the delivery of an intravenous infusion of cocaine (0.5 mg/kg in 32 µl; Coc-SA)
or saline (32 µl/infusion; Sal-SA) and the illumination of a cue light inside the port.
Responses in the second port (inactive) had no consequences. Infusions were delivered on a
fixed ratio 1 schedule with a 10 sec time out for the first 10 infusions or first hour
(whichever occurred first) followed by a 30 sec time out for the remainder of the session.
The number of responses in the active and inactive ports and the number of infusions
obtained were recorded throughout each session. Additional handled control rats (Han) were
treated in an identical manner as self-administration rats, except they were not exposed to
the self-administration chambers. Instead, after recovery from catheter implantation surgery,
they were brought to holding cages away from their colony room where they remained for 6
h before being returned home. This was repeated on 10 consecutive days. These rats were
also flushed with saline before and after being placed in the holding cages. Thus, handled
controls rats experienced the same surgery, recovery, time away from the colony and
handling as self-administration groups. Comparisons between Coc-SA, Sal-SA and Han
groups were made for electrophysiological experiments. Comparisons between Coc-SA and
Han groups were used in the lysed synaptosomal membrane (LP1) fraction. For all other
subcellular fractionation experiments and biotinylation experiments, comparisons were
made between Coc-SA and Sal-SA groups. Sal-SA and Han control groups were used
interchangeably because no differences between these groups were found in
electrophysiological experiments assessing the presence of CP-AMPARs (see Section 3.2).
Furthermore, in biochemical studies, levels of GluA1 and GluA2 proteins in various
fractions did not differ between these two groups (data not shown). Similar Han control
groups have been used in previous studies (Ferrario et al., 2005; Briand et al., 2008a,b). For
biochemical studies, tissue was collected on WD1, WD35 or WD45 following the last self-
administration or handling session. Electrophysiological studies were conducted on
WD30-33. Details of groups compared, N values and withdrawal times are provided below
following the detailed methods for each type of experiment.
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2.3 Whole-cell patch-clamp recordings
Whole-cell patch-clamp recordings were conducted in the presence of NMDAR (APV) and
GABAAR (picrotoxin) antagonists as previously described (Conrad et al., 2008). Briefly, the
rats were anesthetized with chloral hydrate (400 mg/kg, i.p.) before being decapitated.
Brains were rapidly removed into ice-cold artificial cerebral spinal fluid (aCSF) containing
(in mM): 125 NaCl, 25 NaHCO3, 12.5 glucose, 3.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 3
MgCl2, 0.05 APV, and 0.05 picrotoxin (pH 7.45, 295–305 mOsm). Coronal slices (300 µm
thick) containing the NAc were cut in ice-cold aCSF with a Vibratome, and incubated in
warm (~35°C) aCSF solution constantly oxygenated with 95% O2-5% CO2 for at least 60
min before recording. In the recording aCSF (delivered at 2 ml/min), CaCl2 was increased to
2 mM and MgCl2 was decreased to 1 mM. Patch pipettes (6–9 MΩ) were pulled from 1.5
mm borosilicate glass capillaries (WPI, Sarasota, FL) with a horizontal puller (Model P97,
Sutter Instrument, Novato, CA), and filled with a solution containing 0.125 % Neurobiotin
and (in mM): 140 Cs-gluconate, 10 HEPES, 2 MgCl2, 3 Na2-ATP, 0.3 GTP, 0.1 spermine, 1
QX-314 (pH 7.3, 280–285 mOsm). All chemicals and drugs were purchased from Sigma-
Aldrich. Experimental groups used for patch-clamp recording studies: Han (N=6 cells from
3 rats), Sal-SA (N=5 cells from 2 rats), Coc-SA WD30-33 (N=5 cells from 2 rats).
2.4 Tissue collection
One, 35, or 45 days after the last self-administration session (or transport to holding cages
for Han group), rats were decapitated and bilateral samples of the NAc (core and shell) were
rapidly dissected from a 2 mm coronal section obtained using a brain matrix (Activational
Systems, Warren, MI).
2.5 Preparation of LP1 fraction and postsynaptic density fraction (PSD)
The subcellular fractionation method used to obtain these fractions was adapted from Goel
et al. (2006). NAc tissue was homogenized (Wheaton Potter-Elvehjem Tissue Grinders,
Fisher Scientific, Pittsburgh, PA) in HEPES-buffered sucrose (0.32 M sucrose, 4 mM
HEPES, pH 7.4) containing 2 mM EGTA, 50 mM NaF, 10 mM PPi, 1 mM NaOV, 1uM
okadaic acid, 1 mM phenylmethyl sulfonyl fluoride (PMSF), 1 uM microcystin-LF and 1X
protease inhibitor cocktail set 1 (Calbiochem, Darmstadt, Germany). The homogenate was
centrifuged (800 × g, 10 min, 4°C) to remove the pelleted nuclear fraction (P1). The
resulting supernatant (S1) was centrifuged (10,000 × g, 15 min, 4°C) to yield a crude
membrane fraction (P2) which was washed by resuspending in HEPES-buffered sucrose
containing protease and phosphatase inhibitors and centrifuging again. The washed P2
fraction was lysed hypo-osmotically with cold 4 mM HEPES (pH 7.4) with inhibitors and
centrifuged (25,000 × g, 20 min, 4°C) to yield the LP1 fraction, which was re-suspended in
HEPES-buffered sucrose and stored at −80°C. Experimental groups used for analysis of the
LP1 fraction: Han (N=10) and Coc-SA WD45 (N=9).
For PSD preparation, the LP1 was re-suspended in HEPES-buffered sucrose with inhibitors
and run on a discontinuous sucrose gradient (1.2 M, 1.0 M, and 0.8 M sucrose with
inhibitors) and centrifuged (125,000 × g, 2 h, 4° C). The synaptic plasma membrane fraction
(SPM) was collected between 1.0 M and 1.2 M sucrose. The SPM was diluted 2.5 times in 4
mM HEPES with inhibitors and pelleted by centrifugation (150,000 × g, 30 min, 4°C). The
SPM pellet was re-suspended in a 0.5% Triton X-100, HEPES-EDTA solution (50 mM
HEPES, 2 mM EDTA, pH 7.4 with inhibitors), incubated with rotation (15 min, 4°C) and
centrifuged (32, 000 × g, 20 min, 4°C) to pellet the insoluble postsynaptic density fraction
(PSD). The PSD fraction was resuspended in Laemmli sample treatment buffer containing
100mM dithiothreitol (DTT). Samples were then stored at −80°C until used for SDS-PAGE
and Western blotting. Experimental groups used for analysis of PSD fraction: Sal-SA WD1
(N=9), Coc-SA WD1 (N=9), Sal-SA WD45 (N=9), and Coc-SA WD45 (N=7).
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2.6 Preparation of a fraction enriched for extrasynaptic membranes
We used a previously described subcellular fractionation procedure (Davies et al., 2007;
2008; Goebel-Goody et al., 2009) that we have validated in our laboratory (Ferrario et al., in
press). Each NAc sample was homogenized in 3 ml of sucrose homogenization buffer
(10mM HEPES, 0.32M sucrose, 5mM NaF, 1mM NaVO, 2 mM EDTA, pH 7.4) in a glass
grinding vessel with a rotating Teflon pestle (Wheaton Overhead Stirrer; 3000 RPM for 12
passes). The homogenate was then processed as described above to yield the P2 fraction.
The P2 fraction was washed twice with sucrose homogenization buffer and re-suspended in
4 ml of HEPES-buffered sucrose, containing 0.5% Triton X-100 (0.5% v/v), using a
motorized pellet pestle mixing/grinding rod (Kontes, Vineland, NJ) in an ultracentrifuge
tube. The suspension was then incubated with gentle rotation (20 min, 4°C) and centrifuged
(32,000 × g, 20 min) to yield the insoluble pellet (enriched for synaptic membranes) and the
soluble fraction (enriched for extrasynaptic membranes). Both fractions were used for initial
validation studies in tissue from drug-naïve rats (Ferrario et al., in press) but the insoluble
fraction was not analyzed for the present experimental groups because it is redundant with
the PSD fraction described in Section 2.5. The extrasynaptic membrane fraction was
concentrated by adding 8 volumes of cold acetone, incubating overnight (−20°C), and
centrifuging (3000 × g). The concentrated pellet was solubilized in sucrose-Triton buffer
containing 1% SDS. The samples were stored at −80°C. For SDS-PAGE analysis of
extrasynaptic membrane fractions, 5 ug of protein per lane was loaded onto gels. Samples
were stored at −80°C until analysis. Experimental groups used for analysis of extrasynaptic
membranes: Sal-SA WD45 (N=12); Coc-SA WD45 (N=8).
2.7 Biotinylation
Bilateral pieces of NAc tissue from each rat were dissected using a brain matrix and
chopped into 400 µm slices using a McIllwain tissue chopper (The Vibratome Company,
O’Fallon, MO). The tissue was added to eppendorf tubes containing ice-cold aCSF with 1
mM sulfo-NHS-S-S-Biotin (Thermo Scientific, Rockford, IL) and incubated at 4°C with
gentle agitation for 30 min. Samples were then incubated at 4°C for 10 min in glycine (100
mM) to quench the reaction. The tissue was pelleted, re-suspended in ice-cold lysis buffer
[25 mM HEPES pH 7.4, 500 mM NaCl, 2 mM EDTA, 20 mM NaF, 10 mM NaPPi,1 mM
PMSF, 0.1% NP-40 (v/v), 1mM NaOV, 1 uM okadaic Acid, 1 uM microsystin-LF, 1X
protease inhibitor cocktail (Calbiochem; 539131)], sonicated, and stored at −80°C as
described previously for protein crosslinking experiments (Boudreau and Wolf, 2005;
Ferrario et al., 2010). Biotinylation and protein crosslinking experiments are identical except
for the fact that different reagents (sulfo-NHS-S-S-Biotin and BS3, respectively), are used to
selectively modify cell surface proteins. Procedures for purifying biotinylated proteins were
adapted from Thermo Scientific product instructions
(http://www.piercenet.com/files/0682as4.pdf). Protein concentrations were determined using
the Bradford Assay. An aliquot of each NAc sample (100 µg) was added to 37.5 µl of high
capacity NeutrAvidin agarose beads (Cat. No. 29204, Thermo Scientific) and incubated
overnight at 4°C on an end-over-end rotator. Biotinylated proteins bound to NeutrAvidin
beads (bound fraction) were isolated from the nonbiotinylated (unbound) fraction by
centrifugation (3,000 RPM, 1 min) and washed several times in 1X PBS. The biotinylated
fraction was then dissolved in Laemmli sample buffer with DTT (100 mM) and heated at
97°C for 3 min to release the biotinylated proteins from the beads. The samples were then
spun at 10,000 RPM for 5 min on a centrifugal filter unit (0.45 µm, #UFC30HV00,
Millipore, Billerica, MA) to remove the NeutrAvidin beads from the solution. The samples
were then used for immunoblotting as described in Section 2.8. Experimental groups used
for analysis of biotinylated tissue: Sal-SA WD35 (N=12); Coc-SA WD35 (N=9).
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2.8 SDS-PAGE and immunoblotting
All samples were heated at 70°C for 10 min in Laemmli sample treatment buffer with
100mM DTT and then processed for SDS-PAGE and immunoblotting as described
previously (Ferrario et al., 2010) using the following primary antibodies: GluA1 (1:1000,
PA1-37776, Thermo Scientific or 1:1000, AB1504 or MAB2263, Millipore); pS845 GluA1
(1:500, p1160-845, PhosphoSolutions, Aurora, CO; or 1:500, 2491-1, Epitomics,
Burlingame, CA); GluA2 (1:200, 75-002, UC Davis/NIH NeuroMab Facility, Davis, CA or
1:1000, AB1768, Millipore); GluA3 (1:500, 3437, Cell Signaling, Danvers, MA); γ2
(1:1000, 1505-STAR, PhosphoSolutions); γ4 (1:1000, AB5795, Millipore); PSD-95
(1:20,000, 75-028, UC Davis/NIH NeuroMab Facility); CaMKIIα (1:20,000, MAB8699,
Millipore); CaMKIIβ (1:500, ab34703; AbCam, Cambridge, MA), pCaMKIIα/β (1:5000,
p1005-286, PhosphoSolutions); total ERK1/2 (1:10,000, AB3053, Millipore); pERK1/2
(1:10,000, AB3826, Millipore). Total and phospho-CaMKI antibodies were the generous
gift of Dr. Naohito Nozaki (Department of Biochemistry and Molecular Biology, Kanagawa
Dental College, Kanagawa, Japan). Membranes were washed in TBS-T solution, incubated
at RT for 60 min with HRP-conjugated anti-rabbit or mouse IgG (1:10,000; Invitrogen,
Carlsbad, CA), washed with TBS-T, and rinsed with ddH2O. Membranes were then
immersed in chemiluminescence (ECL) detecting substrate (GE Healthcare, Piscataway,
NJ). Images of immunoblots were taken on film and quantified using Total Lab (Life
Sciences Analysis Essentials). A background value was obtained and diffuse densities for
bands of interest in each lane were determined. Because the PSD sample is solubilized
directly in SDS, measures of protein concentration in the PSD fraction were unreliable.
Therefore, PSD samples were loaded according to volume. All other samples were loaded
according to protein concentration. For LP1 and biotinylated (surface) samples, diffuse
densities were normalized to total protein in the lane determined by Ponceau-S stain. For
data obtained using extrasynaptic membrane fractions, diffuse densities were normalized to
µg of protein loaded as described previously (Ferrario et al., in press) because Ponceau-S
staining was too weak. Comparisons were made between experimental and control groups
using one-way ANOVAs and unpaired t-tests when appropriate. In all cases, Coc-SA groups
were compared to a Sal-SA or Han control group killed on the same day, in order to avoid
variability due to potential differences between control groups (e.g., related to age or
duration of single housing). Data are presented as mean ± S.E.M. expressed as percent of
control. For some proteins, we were unable to quantify immunoreactivity for some lanes due
to an unclear band, smudge on the blot or air bubble obstructing the signal. Therefore, the N
for western blotting data may vary from the total number of rats treated. Degrees of freedom
are given throughout so that N can be determined.
3. Results
3.1 Self-administration
Rats self-administered cocaine for 6 h/day for 10 days, as in our previous study (Conrad et
al., 2008). All of these rats (Coc-SA groups) readily acquired cocaine self-administration
and no significant differences in drug intake were found between different cohorts of rats
(data not shown). Controls either self-administered saline (Sal-SA groups) or were treated
identically to Sal-SA rats except for exposure to the self-administration chamber (Han
groups); see Methods for more details. Fig. 1A shows the average number of infusions of
cocaine (closed squares) or saline (open circles) taken per session from all four self-
administration cohorts.
3.2 Electrophysiological demonstration of CP-AMPARs in NAc of Coc-SA rats on WD30-33
After prolonged (42–47 days) but not short (1 day) withdrawal from the same cocaine self-
administration used herein, we demonstrated that CP-AMPARs are incorporated into
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excitatory synapses on medium spiny neurons of the rat NAc core (Conrad et al., 2008). In
the current study, we confirmed these results by randomly selecting Han, Sal-SA and Coc-
SA rats from one cohort of rats destined for biochemical studies. NAc slices were obtained
from these rats on WD30-33 and used for whole-cell patch-clamp recordings of medium
spiny neurons in the NAc core. The presence of CP-AMPARs was evaluated from the
rectification index (RI), defined as the ratio of evoked excitatory postsynaptic currents
(EPSCs) recorded at −70mV and +40mV. Both CP- and CI-AMPARs contribute to
EPSC−70mV whereas only CI-AMPARs are responsible for EPSC+40mV due to voltage-
dependent block of CP-AMPARs by intracellular polyamines. Thus, an increase in the RI
indicates a higher synaptic content of CP-AMPARs. As expected from our past results,
neurons from all Coc-SA rats showed a significantly higher RI than neurons from Sal-SA
and Han groups (Fig. 1B; one-way ANOVA: F(1,2) = 16.6, p<.001; post-hoc Han vs COC-
SA and SAL-SA vs Coc-SA: p values <.0001). These data confirm that the cocaine self-
administration regimen used here reliably leads to incorporation of CP-AMPARs into NAc
synapses and that these receptors can be detected as early as WD30. It should be noted that
no differences were observed between neurons recorded from Sal-SA and Han control
groups.
3.3 Analysis of AMPAR levels in PSD and LP1 fractions prepared from the NAc
Based on electrophysiological results indicating a contribution of CP-AMPARs to synaptic
currents after prolonged withdrawal, and biochemical data indicating that these receptors are
GluA1-containing (Conrad et al., 2008), we predicted that Coc-SA rats should show an
increase in GluA1 protein in the PSD fraction. To test this, we prepared PSD fractions from
the NAc of four experimental groups: Sal-SA WD1, Sal-SA WD45, Coc-SA WD1 and Coc-
SA WD45. To our surprise, no significant differences in GluA1 total protein levels were
found. In fact, a slight decrease in GluA1 protein in the PSD was detected in the Coc-SA
WD45 group (Fig. 2A). In addition, no changes in GluA2 or GluA3 protein levels in the
PSD were evident (Fig. 2C,D). Next we examined two TARPs, γ2 and γ4, which we have
previously shown to be enriched in synaptic and extrasynaptic membranes, respectively, in
the NAc of drug-naïve adult rats (Ferrario et al., in press). The Coc-SA WD45 group
showed a trend towards decreased γ2 levels in the PSD (Fig. 2B, inset), whereas γ4 could
not be detected in the PSD (data not shown), consistent with its primarily extrasynaptic
location in the NAc (Ferrario et al., in press). Interestingly, γ2 levels were correlated with
GluA1 levels, but not with GluA2 or GluA3 levels, in all groups. Accordingly, the loss of
GluA1 in the Coc-SA WD45 group was accompanied by a similar loss of γ2 (Fig. 2B; r=.68,
p<.05). Given that CP-AMPARs are readily detected in NAc synapses of “incubated rats”
using electrophysiological techniques (Fig. 1B; Conrad et al., 2008) and that increases in
cell surface and total GluA1 have also been detected in these rats (Conrad et al., 2008 and
below), we propose that the decrease in GluA1 in the PSD fraction is due to weak anchoring
of CP-AMPARs at the synapse compared to GluA2-containing AMPARs, resulting in their
loss during the preparation of the PSD fraction.
To evaluate this possibility, we prepared an LP1 fraction, hypothesizing that loosely
anchored receptors would be retained in this cruder membrane fraction (which has not been
exposed to detergent; see Methods). Consistent with our earlier findings (Conrad et al.,
2008), GluA1 protein levels in the LP1 fraction were significantly increased on WD45 in the
NAc of the Coc-SA group compared to Han controls (Fig. 3A; t17=1.7, p<.05). Levels of the
TARPs γ2 and γ4 were also elevated in the LP1 fraction of the Coc-SA group, although
these trends did not reach statistical significance (Fig. 3B). Furthermore, GluA2 levels were
unaltered (Fig. 3C) whereas GluA3 levels were decreased (Fig. 3D; t17=2.1, p=0.05). These
data are consistent with the addition of GluA1-containing CP-AMPARs (and associated
TARPs) to synaptic membranes during incubation. Furthermore, they support our hypothesis
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that the decrease in GluA1 in the PSD fraction of the Coc-SA WD45 group was a result of
steps leading to PSD purification.
3.4 Analysis of AMPAR surface expression in the NAc using biotinylation
In our initial study (Conrad et al., 2008), we found an increase in surface expression of
GluA1 (but not GluA2) in Coc-SA rats on WD45 using a BS3 protein crosslinking assay.
We wanted to confirm this result in the present study and also evaluate surface expression of
pS845 GluA1 (based on the role of S845 phosphorylation in the insertion of GluA1 into
extrasynaptic regions of the plasma membrane; see Discussion) and the TARPs γ2 and γ4.
Unfortunately, despite advantages of the BS3 assay with respect to accuracy and efficiency
(Boudreau and Wolf, 2005), we could not accomplish our present goals using this assay
because phospho-specific GluA1 antibodies and TARP antibodies do not recognize their
targets after BS3 crosslinking (data not shown). As an alternative approach, we biotinylated
NAc tissue from Coc-SA and Sal-SA groups killed on WD35. The biotinylated fraction,
containing surface-expressed proteins, was immunoblotted using GluA1 and GluA2
antibodies. Cell surface GluA1 was significantly increased in the Coc-SA compared to the
Sal-SA group (Fig. 4A; t16= 2.8, p<.05), while total GluA2 was not changed (Fig. 4A).
These data confirm previous BS3 crosslinking results indicating an increase in cell surface
GluA1 but not GluA2 in the Coc-SA group (WD45; Conrad et al., 2008) and are consistent
with electrophysiological evidence for CP-AMPARs on WD30-33 (Fig. 1B) and the
selective increase in GluA1 protein in the LP1 fraction on WD45 (Fig. 3). We note that the
increase in surface GluA1 detected with biotinylation on WD35 is smaller than the increase
found in our prior BS3 crosslinking studies. Thus, GluA1 surface values for individual rats
in the biotinylation experiment ranged from 109–164% of control, whereas values in the
prior crosslinking experiments ranged from 129–304% of control (4 experimental cohorts;
Conrad et al., 2008). Differences in the magnitude of the GluA1 increase could be due to
differences in tissue processing between biotinylation and BS3 crosslinking, the GluA1
antibody used (the GluA1 antibody employed in Conrad et al., 2008 was no longer useable
at the time the present experiments were conducted), or the withdrawal day (WD30-33
versus WD42-47; however it should be noted that the RI did not differ between these
withdrawal times, as shown in Fig. 1B). Total drug intake did not vary significantly between
the Coc-SA cohorts in the present study and in Conrad et al. (2008).
Interestingly, in addition to an increase in surface GluA1 on WD35, immunoblotting
analysis of the biotinylated fraction with a phospho-specific antibody revealed a significant
increase in pS845 GluA1 levels in the Coc-SA group compared to the Sal-SA group (Fig.
4A; t15=2.7, p<.05). Because both surface GluA1 and pS845GluA1 increased in the Coc-SA
group, their ratio (pS845 GluA1/total GluA1) did not differ between groups (Fig. 4A). These
results suggest that new GluA1-containing AMPARs added to the cell surface during
cocaine withdrawal are phosphorylated on serine 845. Surface expression of γ4 was also
significantly increased in the Coc-SA group compared to the Sal-SA group (Fig. 4B; t17=
2.4, p<.05), whereas γ2 levels were unchanged (Fig. 4B). This change in γ4 and not γ2
levels is particularly interesting considering that γ2 moved in parallel to GluA1 in the PSD
fraction and that γ4 is not readily detectable in synaptic membranes in the NAc (Ferrario et
al., in press; see Discussion)
3.5 Analysis of AMPAR subunits in extrasynaptic membranes from the NAc
The biotinylation studies described in Section 3.4 show that GluA1-containing AMPARs
(phosphorylated at S845) increase on the cell surface after cocaine withdrawal, but this
approach does not discriminate between GluA1 located at synaptic versus extrasynaptic
sites. Electrophysiological data indicate that some of the new CP-AMPARs are found in
synapses after cocaine withdrawal, but the extrasynaptic accumulation of CP-AMPARs
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could contribute to the observed increase in surface and LP1 levels of GluA1. Extrasynaptic
CP-AMPARs are also of interest because they may supply the synaptic CP-AMPAR pool
(see Discussion). To assess the possibility that some CP-AMPARs accumulate at
extrasynaptic sites, we used a previously described subcellular fractionation procedure to
isolate an extrasynaptic membrane-enriched fraction (Davies et al., 2007, 2008; Goebel-
Goody et al., 2009). We have previously validated this procedure in our own laboratory by
analyzing levels of marker proteins for different subcellular compartments. For example,
synaptic markers [PSD-95 and Ca2+/calmodulin-dependent protein kinase II (CaMKII)] are
virtually undetectable in extrasynaptic membranes. In addition, we used this protocol to
demonstrate that extrasynaptic membranes from the NAc of drug-naïve rats contain
GluA1-3, albeit at lower levels than found in synaptic membranes, and that homomeric
GluA1 receptors can be detected in extrasynaptic membranes (Ferrario et al., in press).
Fig. 5 shows immunoblotting results obtained using extrasynaptic membranes from the NAc
of Coc-SA and Sal-SA groups killed on WD45. Although GluA1 levels in this fraction did
not increase significantly in the Coc-SA WD45 group, we did find a significant increase in
the ratio of pS845 GluA1 to total GluA1 protein levels (Fig. 5; t15=2.1, p<.05). Taken along
with the increase in GluA1 protein on the surface and in the LP1 fraction, these data may
suggest an increase in the fraction of extrasynaptic GluA1-containing AMPARs primed for
synaptic insertion by S845 phosphorylation (see Discussion).
3.6 Analysis of signaling pathways in NAc PSD fractions
Using the same PSD fractions used for analysis of AMPAR subunits (Fig. 2), we examined
several protein kinases that have been linked to AMPAR plasticity. We began with CaMKII
because of its critical role in AMPAR synaptic insertion (Hayashi et al., 2000). In the PSD
fraction, the ratio of phosphorylated CaMKII (Thr286) to total CaMKII was significantly
increased in the Coc-SA WD45 group compared to the Sal-SA WD45 group; this was
observed for both α and β CaMKII isoforms (Fig. 6A; t14=2.1, p<.05; Fig. 6B; t14=2.2, p<.
05). The increased ratios in the Coc-SA WD45 group reflected small increases in
phosphorylated CaMKII combined with small decreases in total CaMKII (data not shown).
We also evaluated CaMKI because it has been implicated in synaptic insertion of CP-
AMPARs in the hippocampus (Guire et al., 2008;Fortin et al., 2010), but no differences in
CaMKI phosphorylation or total levels were observed between experimental groups (Fig.
6C). Next we examined extracellular signal-regulated kinase (ERK) because its activation
also plays a role in AMPAR synaptic incorporation (Zhu et al., 2002). In the PSD fraction,
total levels of ERK1 and ERK2 were not significantly altered by cocaine exposure, though
there was a trend towards an increase in both isoforms in the Coc-SA WD1 group compared
to control (Fig. 7A). Similarly, there was a trend towards an increase in pERK2 in the Coc-
SA WD1 group, as well as a smaller trend in the Coc-SA WD45 group (Fig. 7B). The ratio
of pERK2/total ERK2 protein was significantly increased in PSD fractions from Coc-SA
groups on both WD1 and WD45 compared to Sal-SA groups (Fig. 7C; WD1, t16=1.7, p<.05;
WD45, t14=1.8, p<.05) The pERK1 signal in the PSD fraction was too weak to reliably
quantify.
4. Discussion
In drug-naïve adult rats, NAc synapses contain very low levels of CP-AMPARs (Conrad et
al., 2008; Reimers et al., 2010). However, GluA1-containing CP-AMPARs (homomeric
GluA1 or GluA1A3 receptors) accumulate in NAc synapses after withdrawal from extended
access cocaine self-administration (Conrad et al., 2008). Most importantly, these CP-
AMPARs mediate the expression of incubated cue-induced cocaine seeking on WD45. This
CP-AMPAR dependent enhancement of drug seeking behavior may be due to an increase in
the reactivity of NAc medium spiny neurons to glutamate as a result of the higher
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conductance of CP-AMPARs compared to the CI-AMPARs that normally dominate in NAc
synapses. Incorporation of only a small number of these high conductance CP-AMPARs can
significantly increase synaptic strength (Guire et al., 2008).
In humans, it is relatively common for cocaine users to become abstinent for a month or so
due to incarceration or hospitalization (Reichel and Bevins, 2009), a period of time that is
sufficient for incubation (Lu et al., 2004) and synaptic incorporation of CP-AMPARs in the
NAc in rats (present results). If incubation occurs in humans, as indicated by a recent study
(Bedi et al., 2010), and if addition of CP-AMPARs also participates in enhanced drug
seeking and craving in human cocaine addicts, then blocking or removing CP-AMPARs
should help a recovering addict remain abstinent. Unfortunately, the known CP-AMPAR
blockers are neurotoxins, so other strategies must be found. To aid in the development of
such strategies, it is important to understand where CP-AMPARs are expressed in NAc
neurons and what mechanisms enable them to accumulate in these synapses (from which
they are largely excluded under normal conditions). We approached this problem by using
subcellular fractionation and biotinylation to analyze AMPAR subunit and TARP
distribution in the NAc of “incubated rats” on WD30-45.
Subcellular location of CP-AMPARs in the NAc of “incubated rats”
Consistent with prior protein crosslinking results (Conrad et al., 2008), the LP1 and
biotinylation studies presented here indicated increased surface expression of GluA1 but not
GluA2 in the NAc of Coc-SA rats on WD35, suggesting increased surface expression of CP-
AMPARs. Confirming this, electrophysiological studies detected inwardly rectifying
AMPAR excitatory postsynaptic currents (EPSCs) on WD30-33. Inward rectification is a
hallmark of CP-AMPARs (Cull-Candy et al., 2006). We had previously used
electrophysiological approaches to demonstrate the presence of CP-AMPARs on WD42-47,
although biochemical results suggested that they were present even earlier in withdrawal
(Conrad et al., 2008). In a mouse study, Mameli et al. (2009) detected CP-AMPARs in the
NAc shell on WD35 after a similar cocaine self-administration regimen. Because these
electrophysiological experiments assess synaptic responses, they establish that at least some
of the new CP-AMPARs detected biochemically are located in synapses. However, our
results suggest that synaptic CP-AMPARs are more loosely anchored to the PSD than
GluA1A2-containing AMPARs, because increased GluA1 levels were detectable in a LP1
fraction from Coc-SA rats on WD45 (i.e., a fraction not exposed to detergent) whereas
levels of GluA1 (and γ2) were slightly decreased in a PSD fraction from identically treated
rats.
To determine if extrasynaptic CP-AMPAR levels are also increased, we measured GluA1 in
a fraction enriched for extrasynaptic membranes. Starting with NAc tissue from adult drug-
naïve rats, we showed previously that GluA1-3 subunits are detected in this fraction, albeit
at lower levels than in synaptic membranes, and that some extrasynaptic AMPARs are
homomeric GluA1 receptors (Ferrario et al., in press). Here we found that GluA1 levels in
extrasynaptic membranes were not significantly increased in the Coc-SA group compared to
the Sal-SA group on WD45 (although GluA1 phosphorylation in extrasynaptic membranes
of the Coc-SA group was significantly increased, as discussed below). It is well established
that AMPARs diffuse in the extrasynaptic membrane, and between extrasynaptic and
synaptic areas, although their mobility decreases substantially once they enter synapses (e.g.,
Borgdoff and Choquet, 2002; Heine et al., 2008; Opazo et al., 2010). Thus, our finding of no
significant change in total GluA1 in extrasynaptic membranes, but an increase in CP-
AMPAR levels in synapses, may indicate more efficient transfer of CP-AMPARs from
extrasynaptic to synaptic pools in the Coc-SA group (although their anchoring to the
synapse may be relatively weak; see previous paragraph). However, we cannot exclude the
possibility that a functionally significant increase in extrasynaptic GluA1 occurred which
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was below the limit of detection of our biochemical techniques. Total surface levels of
GluA1, measured with biotinylation, were increased ~40% above control (Fig. 4). If this
increase is split between synaptic and extrasynaptic GluA1 pools, then the magnitude of the
change in the extrasynaptic pool might be very small, particularly since GluA1 is more
abundant in synaptic membranes than extrasynaptic membranes (Ferrario et al., in press).
Indeed, a small trend towards an increase in extrasynaptic GluA1 is apparent in Fig. 5.
Ultimately, this issue could be further examined using electrophysiological techniques.
Cocaine alters distribution of TARPs in the NAc
Type I TARPs (γ2, γ3, γ4 and γ8) are auxiliary AMPAR subunits that associate with
AMPARs early in their biosynthesis and then regulate both their trafficking and channel
function (Ziff, 2007; Kato et al., 2010). γ2 and γ4 are expressed in the NAc, although
interestingly γ2 is enriched in synaptic membranes but present in extrasynaptic membranes,
whereas γ4 is mainly expressed in extrasynaptic membranes (Ferrario et al., in press). In
fact, γ4 cannot be detected in PSD fractions from either drug-naïve rats (Ferrario et al., in
press) or Coc-SA rats (present results). The presence of γ2 and γ4 in our NAc samples is
consistent with prior studies showing γ2 and γ4 in the NAc and other striatal regions
(Klugbauer et al., 2000; Sharp et al., 2001; Tomita et al., 2003; Fukaya et al., 2005). These
studies also detected γ3 and γ8 in striatal tissue. However, lack of a selective antibody
precluded our investigation of γ3, and γ8 does not appear to be expressed by NAc medium
spiny neurons, at least in primary cultures (C.R. Ferrario and M.E. Wolf, unpublished
observations). Two subfamilies of Type I TARPS are now recognized: Type Ia (γ2 and γ3)
and Type Ib (γ4 and γ8). Both subfamilies regulate AMPAR trafficking, but Type Ib TARPs
produce a more dramatic enhancement of AMPAR currents (Kato et al., 2010), suggesting
functional consequences of the different distribution of γ2 and γ4 in the NAc (Ferrario et al.,
in press).
Our results provide the first evidence that TARPs are affected by cocaine exposure. First,
indirect evidence from the PSD fraction (see Section 3.3) suggests that the new CP-
AMPARs in synapses are associated with γ2. However, the Coc-SA group exhibited a trend
towards increased γ2 and especially γ4 in the LP1 fraction, suggesting that some new CP-
AMPARs contain γ4. These may be extrasynaptic CP-AMPARs, since very little γ4 is
detected in synaptic membranes (see previous paragraph). Furthermore, increased γ4 surface
expression was found in biotinylated NAc tissue, which includes the extrasynaptic surface
AMPAR pool. Further interpretation of our results is difficult because the stoichiometry of
TARPs in AMPAR tetramers remains unclear and may be cell specific, and because it is not
clear whether a given AMPAR tetramer can contain more than one TARP isoform (see
Tomita et al., 2003; Shi et al., 2009; Kim et al., 2010). Despite these questions, given that
TARP phosphorylation state regulates AMPAR synaptic targeting (see next section), it is
possible that cocaine influences AMPAR trafficking in part through mechanisms that
involve TARPs.
Role of GluA1 phosphorylation in CP-AMPAR accumulation
GluA1 phosphorylation is regulated in concert with synaptic plasticity and influences both
channel function and receptor trafficking (Derkach et al., 2007; Shepherd and Huganir,
2007; Lin et al., 2009; Lu et al., 2010). We focused on S845, which is phosphorylated by
protein kinase A (Roche et al., 1996; Mammen et al., 1997). Phosphorylation of S845 can
increase AMPAR open probability (Banke et al., 2000) although the majority of recent
studies have focused on its role in AMPAR trafficking. In NAc neurons, we have shown that
GluA1-containing AMPARs are incorporated into synapses via a two-step process. They are
first inserted onto the cell surface at extrasynaptic sites, and then translocated into synapses
in an NMDA receptor-dependent manner. The first step is accelerated by PKA activation,
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most likely via phosphorylation of S845 in GluA1 (Chao et al., 2002a,b; Mangiavacchi and
Wolf, 2004; Sun et al., 2008; for review, see Wolf, 2010b). Studies in other brain regions
similarly indicate that PKA phosphorylation of GluA1 primes AMPARs for synaptic
insertion (Esteban et al., 2003; Sun et al., 2005; Oh et al., 2006; Gao et al., 2006; Man et al.,
2007) and that extrasynaptic surface AMPARs are important for supplying the synapse
(Passafaro et al., 2001; Sun et al., 2005; Gao et al., 2006; Yudowski et al., 2007; Heine et
al., 2008; Yang et al., 2008; Lin et al., 2009; Makino and Malinow, 2009). Particularly
relevant to our study, perisynaptic CP-AMPARs are important for increasing synaptic
strength during some types of LTP (Guire et al., 2008; Yang et al., 2010).
Recently, we found that pS845 GluA1 is enriched in extrasynaptic membranes (relative to
synaptic membranes) from the NAc of adult drug-naïve rats (Ferrario et al., in press). In the
present study, we observed an increase in the pS845 GluA1/total GluA1 ratio in the
extrasynaptic membrane fraction from the Coc-SA WD45 group compared to Sal-SA
controls. We also observed increased pS845 GluA1 on the cell surface in the Coc-SA WD35
group (biotinylation experiments). These results suggest that a greater portion of the
extrasynaptic GluA1 is phosphorylated at S845 in “incubated rats”. In light of evidence that
S845 phosphorylation primes GluA1-containing AMPARs for synaptic insertion (above),
the observed increase in extrasynaptic pS845 GluA1 could play a causal role in the elevation
of synaptic CP-AMPAR levels that we observe in electrophysiological studies on WD30-47.
Interestingly, a recent study showed that S845 phosphorylation stabilizes perisynaptic
GluA1-containing CP-AMPARs in hippocampus, preventing their degradation (He et al.,
2009). However, this would predict an increase in total GluA1 protein in the extrasynaptic
pool, which we did not observe, although a small effect cannot be ruled out (see second
section of Discussion). An increase in S845 GluA1, in concert with addition of GluA1-
containing CP-AMPARs to hippocampal synapses, has also been reported 12 h after
discontinuing repeated morphine injections (Billa et al., 2010).
Candidate signaling mechanisms for CP-AMPAR plasticity during incubation
We studied signaling pathway activation in PSD fractions from Coc-SA rats to learn about
mechanisms that may underlie CP-AMPAR accumulation. CaMKII was studied because its
activation is required for activity-dependent synaptic insertion of GluA1-containing
AMPARs although GluA1 is not the relevant substrate (Hayashi et al., 2000). Instead, recent
evidence indicates that activity-dependent translocation of CaMKII to the PSD leads to
phosphorylation of γ2, facilitating γ2 binding to PSD-95; this promotes synaptic retention of
γ2 and associated GluA1-containing receptors (Opazo et al., 2010). Phosphorylation of γ2
may promote its binding to PSD-95 by dissociating γ2 from lipid bilayers; the lipid
interaction inhibits γ2 binding to PSD-95 (Sumioka et al., 2010). Given that we observed an
increase in pCaMKII/total CaMKII in the PSD fraction of the Coc-SA WD45 group, it is
possible that the mechanism identified by Opazo et al. (2010), activated persistently, could
underlie our observations of higher levels of GluA1-containing AMPARs in the LP1
fraction and on the cell surface in the biotinylation experiments (γ2 and γ4 showed trends
towards increases in the LP1 fraction, although only surface γ4 increased in the biotinylation
experiment). It would be interesting to determine if TARP phosphorylation is increased in
the NAc of “incubated rats”, but we have been unable to resolve different TARP
phosphorylation states in NAc tissue using electrophoresis or other methods and no
phospho-specific antibodies are available. It is also possible that the increase in CaMKII
activation in the Coc-SA group is a consequence of the presence of CP-AMPARs in the
membrane, as they would provide a new source of Ca2+ entry that could lead to CaMKII
activation.
Prior work has implicated CaMKII in cellular and behavioral changes involving the NAc
that are produced by repeated psychostimulant exposure, but this work has been conducted
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after non-contingent drug treatment (e.g., Pierce and Kalivas, 1997; Pierce et al., 1998;
Boudreau et al., 2009; Loweth et al., 2010) or limited access drug self-administration (e.g.,
Anderson et al., 2008; Loweth et al., 2008; Wang et al., 2010). Interestingly, in the latter
experimental situation, cocaine-primed reinstatement was shown to require a rapid CaMKII
dependent increase in cell surface GluA1 associated with GluA1 phosphorylation at S831
(Anderson et al., 2008). However the time course of this effect (AMPAR changes were
detected 30 min after the priming injection of cocaine) is markedly different from the
extremely persistent increases in GluA1 surface expression (weeks to months) that we are
studying in the incubation model. Somewhat more analogous are studies showing that over-
expression of CaMKII for several days led to an increase in AMPAR-mediated responses in
the NAc (Loweth et al., 2010; Singer et al., 2010), although the time-scale is still quite
different.
When comparing our results to studies using other cocaine self-administration procedures, it
is important to recognize that we do not know whether CP-AMPAR levels increase in the
NAc after prolonged withdrawal from limited access cocaine self-administration (see Wolf
and Ferrario, 2010 for more discussion). All of the evidence for CP-AMPAR accumulation
has been obtained after withdrawal from extended access cocaine self-administration
(Conrad et al., 2008; Mameli et al., 2009; present study). Extended access self-
administration produces different behaviors compared to limited access cocaine self-
administration, suggesting that the two experiences do not produce equivalent
neuroadaptations. Based on the behavioral differences, extended access is believed to more
closely model the compulsive drug seeking and taking characteristic of addiction than
limited access procedures (Ahmed and Koob, 1998; Vanderschuren and Everitt, 2004;
Ferrario et al., 2005; Ben-Shahar et al., 2009). It will be interesting to test for CP-AMPARs
after prolonged withdrawal from very long duration cocaine self-administration regimens
(8–10 weeks); striking individual differences in NAc synaptic plasticity are evident 24 h
after discontinuing such a regimen (Kasanetz et al., 2010).
We also evaluated CaMKI based on evidence that it mediates redistribution of CP-AMPARs
from extrasynaptic pools to the synapse during theta-burst stimulation (TBS) induced LTP
(Guire et al., 2008) as well as the spine enlargement that accompanies AMPAR synaptic
insertion (Fortin et al., 2010). However, we found no evidence for CaMKI activation in the
PSD fraction (or LP1; data not shown) of Coc-SA rats. This is not surprising in light of
differences between the two situations. Hippocampal LTP is a rapidly occurring form of
synaptic strengthening elicited by a relatively discrete stimulus. With some paradigms (e.g.,
TBS), the initial synaptic strengthening depends on synaptic incorporation of CP-AMPARs
but these are replaced within 20–30 min by CI-AMPARs (Plant et al., 2006; Guire et al.,
2008). In contrast, in the incubation model, CP-AMPARs are added to NAc synapses over
weeks (Conrad et al., 2008), and then remain in synapses for at least 69 days (K.Y. Tseng,
unpublished findings). At least from the perspective of timing of onset, this is more
reminiscent of homeostatic plasticity than Hebbian plasticity (see Sun and Wolf, 2009 for
more discussion) and it is therefore not surprising that different mechanisms underlie CP-
AMPAR plasticity in these two situations. The time course of our effect also contrasts with
studies showing CP-AMPAR synaptic incorporation in other brain regions during the first
day after discontinuing cocaine, morphine or benzodiazepine exposure (e.g., Bellone and
Lüscher, 2006; Song et al., 2007; Argilli et al., 2008; Billa et al., 2010; Good and Lupica,
2010).
ERK2 activation is involved in many aspects of addiction-related plasticity (Lu et al., 2006;
Girault et al., 2007) and prior studies have demonstrated that ERK2 activation accompanies
increased cell surface levels of GluA1A2-containing AMPARs in the NAc of rats treated
repeatedly with non-contingent cocaine to produce behavioral sensitization (Boudreau et al.,
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2007, 2009; Schumann and Yaka, 2009). Here, we found that the ratio of pERK2/total
ERK2 was significantly increased in the NAc PSD fraction from Coc-SA rats on both WD1
and WD45. This duration of ERK2 activation is remarkable, although we had previously
found ERK2 activation lasting at least 2 weeks in the NAc of cocaine-sensitized rats
(Boudreau et al., 2009). It is possible that ERK2 activation plays a role in maintaining
GluA1-containing AMPAR upregulation after withdrawal from either non-contingent or
contingent cocaine exposure. Interestingly, the correlation between upregulation of GluA1-
containing AMPARs in the NAc and ERK2 activation is bidirectional: both AMPAR
subunit surface expression and pERK2 increase 24 after withdrawal, whereas subsequent re-
exposure to cocaine normalizes both measures (Boudreau et al., 2007).
Conclusions
CP-AMPARs are increased in NAc synapses of rats evaluated after withdrawal from
extended access cocaine self-administration (“incubated rats”). This is detected as early as
WD30-33 and persists at least through WD69 (and perhaps beyond), making it among the
more persistent drug-induced neuroadaptations that have been described. Our results suggest
that new CP-AMPARs in NAc synapses are loosely tethered to the PSD and may be
associated with γ2. Increased synaptic levels of CP-AMPARs may result in part from an
increase in S845 phosphorylation of GluA1 in extrasynaptic membranes, given that S845
phosphorylation primes GluA1-containing AMPARs for synaptic insertion and
extrasynaptic AMPARs supply the synapse. Some of the new extrasynaptic CP-AMPARs
are likely associated with γ4, rather than γ2. The maintenance of CP-AMPARs in synapses
across more than a month of withdrawal is accompanied by activation of ERK2;
furthermore, CaMKII but not CaMKI is activated on WD45. Future studies should explore a
role for additional signaling pathways, and examine how these postsynaptic adaptations may
be related to changes in presynaptic glutamate tone (see Wolf, 2010a).
Abbreviations
aCSF artificial cerebral spinal fluid
BS3 bis(sulfosuccinimidyl)suberate
CaMK Ca2+/calmodulin-dependent protein kinase
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ERK extracellular signal-regulated kinase
pS845 GluR1 GluA1 phosphorylated at serine 845
LP1 lysed synaptosomal membranes
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PSD postsynaptic density
TARP transmembrane AMPA receptor regulatory protein
WD withdrawal day
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Self-administration behavior and whole-cell patch-clamp recordings demonstrating presence
of CP-AMPARs. A) Mean number of infusions (± SEM) taken during each 6 hour self-
administration session for saline (N=47; open circles) and cocaine (N=48; closed squares)
groups. All rats readily acquired cocaine self-administration and no significant differences in
drug intake were found between the 4 cohorts studied. B) Rectification index (RI:
EPSC−70mV/EPSC+40mV, ± SEM) determined by whole-cell patch-clamp recordings of NAc
medium spiny neurons 30–33 days after the last self-administration or handling session
(WD30-33). No differences were found between handled (Han) and saline self-
administering groups (Sal-SA). Rats that previously self-administered cocaine had a
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significantly higher RI than both Han and Sal-SA controls, consistent with a greater synaptic
content of CP-AMPARs. The dashed line represents the average RI for the Coc-SA
WD42-47 group in our previous publication using the same self-administration regimen
(Conrad et al., 2008). * p<0.0001.
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Expression of AMPAR subunits and the TARP γ2 in the NAc postsynaptic density (PSD)
fraction after 1 or 45 days of withdrawal from self-administration. Data are presented as
mean (± SEM) expressed as percent of saline controls at each withdrawal time. A) GluA1
protein levels in the Coc-SA group were slightly decreased on WD45 compared to the Sal-
SA WD45 group. B) Data suggesting that γ2 and GluA1 are lost in parallel during
preparation of PSD fractions from the Coc-SA WD45 group. Total γ2 protein decreased
slightly in the Coc-SA WD45 group (inset), similar to the decrease in GluA1 shown in panel
A, and levels of GluA1 protein and γ2 protein were significantly correlated for individual
rats in this group. The dashed lines show confidence interval and the solid line shows best
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fit. C, D) GluA2 and GluA3 protein levels were unchanged in the PSD fraction. In all
panels, blot images from two rats in each group are shown by the two bands directly
underneath each bar. For example, in panel A, the top four bands correspond (from left to
right) to Sal-SA WD1, Coc-SA WD1, Sal-SA WD45 and Coc-SA WD45 rats. The lower
four bands show another set of representative rats from each of these experimental groups.
Ferrario et al. Page 23














Expression of AMPAR subunits and the TARPs γ2 and γ4 in the NAc lysed synaptosomal
membrane (LP1) fraction after 45 days of withdrawal from cocaine-administration (Coc-SA
WD45) or the last handling session (Han). Data are presented as mean (± SEM) expressed as
percent of handled controls. Importantly, Han and Sal-SA groups did not differ on several
measures (see Results), including the RI (Fig. 1). A) GluA1 protein levels were significantly
increased in the Coc-SA group compared to the Han group. B) Levels of γ2 and γ4 were
slightly elevated. C) GluA2 protein levels were unchanged in the Coc-SA group. D) Levels
of GluA3 protein were significantly decreased in the Coc-SA group compared to controls.
Taken together, these data are consistent with an increase in CP-AMPARs in the Coc-SA
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WD45 group. In all panels, blot images from two rats in each group are shown by the two
bands directly underneath each bar. For example, in panel A, the top two bands correspond
(from left to right) to Han and Coc-SA WD45 rats. The lower two bands show another set of
representative rats from each of these experimental groups. *p<.05, #p=.05
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Surface expression of AMPAR subunits and the TARPs γ2 and γ4 after 35 days of
withdrawal from self-administration, determined using biotinylation. Data are presented as
mean (± SEM) expressed as percent of saline self-administering controls. A) Surface
expression of GluA1 was significantly increased in the Coc-SA group compared to controls,
whereas surface expression of GluA2 was unchanged. These data are consistent with
insertion of CP-AMPARs, as also indicated by results in Fig. 1 (WD30-33) and in Fig. 3
(WD45). Surface expression of GluA1 phosphorylated at serine 845 (pS845 GluA1) was
also significantly increased in the Coc-SA group compared to the control group, while the
ratio of pS845 GluA1/total (t) GluA1 was unchanged due to proportional increases in both
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numerator and denominator. B) Surface expression of γ4 was significantly increased in the
Coc-SA group compared to the Sal-SA group, whereas γ2 levels were unchanged. C)
Representative blots for data graphed in panels A and B. Data from one pair of Sal-SA and
Coc-SA rats are shown to the left of the labels, while another pair is shown to the right.
Overall, the data indicate an increase in cell surface GluA1-containing AMPARs
phosphorylated at S845 (see Discussion). *p<.05
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Levels of total GluA1 and GluA1 phosphorylated on S845 (pS845 GluA1) in an
extrasynaptic membrane-enriched fraction prepared after 45 days of withdrawal from self-
administration. Data are presented as mean (± SEM) expressed as percent of saline self-
administering controls. The ratio of pS845 GluA1/total (t) GluA1 was significantly
increased in the Coc-SA group compared to the Sal-SA group. Phosphorylation of GluA1-
containing AMPARs may promote their synaptic incorporation (see Discussion). Blot
images from two rats in each group are shown by the two bands directly underneath each
bar. Thus, the top two bands on the left correspond to GluA1 bands for Sal-SA and Coc-SA
rats, while the two bands directly underneath show GluA1 bands from another pair of Sal-
SA and Coc-SA rats. *p<.05
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Phosphorylation state of CaMKIIα/β and CaMKI in the PSD fraction after 1 or 45 days of
withdrawal from self-administration. Data are presented as mean (± SEM) expressed as
percent of saline controls at each withdrawal time. A) The ratio of pCaMKIIα (50 kD) to
total (t) CaMKIIα was significantly increased on WD45 in the Coc-SA group compared to
the Sal-SA group. B) The ratio of pCaMKIIβ (60 kD) to total CaMKIIβ was also
significantly increased on WD45 in the Coc-SA group. C) CaMKI and pCaMKI levels were
unchanged after withdrawal from cocaine self-administration. D) Representative blots for
data graphed in panels A, B and C. *p<.05
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Levels of ERK1 and ERK2 protein and ERK2 phosphorylation in the PSD fraction after 1 or
45 days of withdrawal from self-administration. Data are presented as mean (± SEM)
expressed as percent of saline controls at each withdrawal time. A) Total levels of ERK1
and ERK2 were slightly elevated on WD1 in the Coc-SA group; however, this did not reach
statistical significance. B) Similar to results for total ERK in panel A, pERK2 levels were
slightly elevated on WD1 in the Coc-SA group, but this was not statistically significant. On
WD45, there was a small trend towards an increase in pERK2 levels in the Coc-SA group.
C) The ratio of pERK2/total (t) ERK2 was significantly increased in the Coc-SA group
compared to Sal-SA controls on both withdrawal days due to larger increases in pERK2 than
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total ERK2. While ratios appear similar for Coc-SA groups on WD1 and WD45 (panel C),
note the larger magnitude of shifts in total ERK2 (panel A) and pERK2 (panel B) on WD1.
Levels of pERK1 in the PSD fraction were too low for reliable quantification.
Representative blots are shown for two rats in each experimental group. In panel A, the top
blot shows ERK1 and ERK2 bands for one rat from the experimental group above the blot,
and the bottom blot shows ERK1 and ERK2 bands for another rat in this group. In panel B,
the top four bands correspond (left to right) to Sal-SA WD1, Coc-SA WD1, Sal-SA WD45
and Coc-SA WD45 rats, while the lower four bands show another set of representative rats
from each of these experimental groups. *p<.05
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